Form 4: Zimmer Biomet SVP Lori Winkler Reports Stock Transactions
SEC Form 4 Filing
Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On March 2, 2024, Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported transactions involving Zimmer Biomet common stock.
- 186 shares were acquired upon the vesting of restricted stock units (RSUs).
- 46 shares were withheld by the company to satisfy tax obligations related to the vesting of the RSUs at a price of $124.28.
- Following these transactions, Winkler directly owns 1,450 shares of Zimmer Biomet common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document is a standard regulatory filing detailing stock transactions.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they relate to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/02/2024 | Date of earliest transaction: vesting of restricted stock units and tax withholding. |
| 03/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.